Cellbxhealth PLC Announces Holding(s) in Company 
Eve & Co Completes Issuance of $550,000 Convertible Debentures
STRATHROY, Ontario, Dec. 14, 2020 (GLOBE NEWSWIRE) -- Eve & Co Incorporated (“Eve & Co” or the “Company”) (TSX-V: EVE;...
CYBIN Closes Acquisition of Adelia Therapeutics; Bolsters Scientific Team and Grows IP Portfolio to 7 Patent Filings
--Newly acquired novel psychedelic molecules diversify Cybin’s development portfolio, providing access to multiple future indications-- --Adelia brings a range of...
Indus Holdings, Inc. Files Final Base Shelf Prospectus
NOT FOR DISTRIBUTION IN THE UNITED STATES OR OVER UNITED STATES WIRE SERVICES SALINAS, Calif., Dec. 14, 2020 (GLOBE NEWSWIRE)...
AMAG Pharmaceuticals Files Submission in Response To the Food And Drug Administration’s Notice of Opportunity for a Hearing and Proposal To Withdraw Approval of Makena® (hydroxyprogesterone caproate injection)
WALTHAM, Mass., Dec. 14, 2020 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. has submitted its response to the FDA’s Notice of...
Phathom Pharmaceuticals Announces Plans to Initiate Vonoprazan Development Program in Non-Erosive Reflux Disease (NERD)
Management and Key Opinion Leaders to discuss NERD and the vonoprazan NERD development program during virtual Investor Day webcast today...
HLS Therapeutics to Webcast Live at Life Sciences Investor Forum December 17th
Company invites individual and institutional investors, as well as advisors and analysts, to attend real-time, interactive presentations on LifeSciencesInvestorForum.comTORONTO, Dec....
Virtual Conference for Life Sciences Companies Broadcast Live December 17th, 2020
Company executives will share corporate vision and answer audience questions at LifeSciencesInvestorForum.comNEW YORK, Dec. 14, 2020 (GLOBE NEWSWIRE) -- Life...
Sarepta Therapeutics Announces Executive Management Changes
-- Ian Estepan named chief financial officer-- Dallan Murray named chief commercial officer-- Louise Rodino-Klapac, Ph.D., named chief scientific officer--...
CYBIN Closes Acquisition of Adelia Therapeutics; Bolsters Scientific Team and Grows IP Portfolio to 7 Patent Filings
--Newly acquired novel psychedelic molecules diversify Cybin’s development portfolio, providing access to multiple future indications-- --Adelia brings a range of...
Motiva Ergonomix2 Platform and Motiva Mia Implant Receive CE Mark
Commercial Launch of Ergonomix2 Planned for 2021Approval Accelerates Path to Europe for Motiva MiaPre-Commercial European Mia Procedures to Begin in...
Capital Senior Living Corporation Residents and Employees Prioritized to Receive the COVID-19 Vaccine
All 104 Operating Communities have been registered and confirmedDALLAS, Dec. 14, 2020 (GLOBE NEWSWIRE) -- Capital Senior Living Corporation (the...
Caladrius Biosciences Provides Year-End 2020 Strategic Portfolio Update
Program strategy and prioritization supports projection of available capital through 2021BASKING RIDGE, N.J., Dec. 14, 2020 (GLOBE NEWSWIRE) -- Caladrius...
BioCardia Anticipates DSMB Feedback on Interim Data From Pivotal Phase 3 CardiAMP Heart Failure Trial
SAN CARLOS, Calif., Dec. 14, 2020 (GLOBE NEWSWIRE) -- BioCardia®, Inc. (Nasdaq: BCDA)(BioCardia or the “Company”) today announces that it anticipates...
X4 Pharmaceuticals Appoints Diego Cadavid, M.D., as Chief Medical Officer
BOSTON, Dec. 14, 2020 (GLOBE NEWSWIRE) -- X4 Pharmaceuticals, Inc. (Nasdaq: XFOR), a leader in the discovery and development of...
Calibre Scientific Enters the Canadian Market and Expands Product Portfolio With the Acquisition of Canadian Life Science
LOS ANGELES, Dec. 14, 2020 (GLOBE NEWSWIRE) -- Calibre Scientific is pleased to announce the acquisition of Canadian Life Science (“CLS”), a...
Aditxt Signs Distribution Agreement with Todos Medical Ltd. For AditxtScore™ for COVID-19 Immune Monitoring Service
Service Availability is Expected in January 2021 MOUNTAIN VIEW, CA and REHOVOT, ISRAEL, Dec. 14, 2020 (GLOBE NEWSWIRE) -- via...
CRISPR Therapeutics Receives Grant to Advance In Vivo CRISPR/Cas9 Gene Editing Therapies for HIV
-Funding from the Bill & Melinda Gates Foundation will support research to enable CRISPR/Cas9-based therapies for HIV that can benefit...
Reflect Scientific Inc. Adds Another Low Temperature Refrigeration Patent Solution to its Growing Intellectual Property Portfolio, and Business Update
OREM, Utah, Dec. 14, 2020 (GLOBE NEWSWIRE) -- Reflect Scientific, Inc. (Symbol: RSCF), a provider of diverse products and services...
Leading UK Core Labs Expand Investment in PacBio Sequencing Systems to Power Life Science Research with HiFi Reads
Edinburgh Genomics, Oxford Genomics Centre, and University of Liverpool Centre for Genomic Research have added new PacBio Sequel II &...
HEXO Corp Reports First Quarter Fiscal 2021 Financial Results
Record Quarter with Gross Revenue of $41.3 MillionAdjusted EBITDA Improves for the Sixth Consecutive Quarter OTTAWA, Dec. 14, 2020 (GLOBE...